Medicago
www.medicago.com/en
www.medicago.com/en
Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine antigens in non-transgenic plants.
Newswire archive
Newswires found: 12
-
06/03/12
-
19/01/12
-
16/01/12
-
30/06/11
-
08/06/11
-
11/01/11
-
22/12/10
-
26/11/10
-
10/08/10
-
02/09/09
-
30/07/09
-
21/07/09
